4J99 image
Entry Detail
PDB ID:
4J99
Keywords:
Title:
Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Gain-of-Function K659T Mutation.
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2013-02-15
Release Date:
2013-08-07
Method Details:
Experimental Method:
Resolution:
1.85 Å
R-Value Free:
0.24
R-Value Work:
0.20
R-Value Observed:
0.20
Space Group:
C 1 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Fibroblast growth factor receptor 2
Mutations:C491A, K659T
Chain IDs:A, B, C, D
Chain Length:324
Number of Molecules:4
Biological Source:Homo sapiens
Primary Citation
Cracking the Molecular Origin of Intrinsic Tyrosine Kinase Activity through Analysis of Pathogenic Gain-of-Function Mutations.
Cell Rep 4 376 384 (2013)
PMID: 23871672 DOI: 10.1016/j.celrep.2013.06.025

Abstact

The basal (ligand-independent) kinase activity of receptor tyrosine kinases (RTKs) promotes trans-phosphorylation on activation loop tyrosines upon ligand-induced receptor dimerization, thus upregulating intrinsic kinase activity and triggering intracellular signaling. To understand the molecular determinants of intrinsic kinase activity, we used X-ray crystallography and NMR spectroscopy to analyze pathogenic FGF receptor mutants with gradations in gain-of-function activity. These structural analyses revealed a "two-state" dynamic equilibrium model whereby the kinase toggles between an "inhibited," structurally rigid ground state and a more dynamic and heterogeneous active state. The pathogenic mutations have different abilities to shift this equilibrium toward the active state. The increase in the fractional population of FGF receptors in the active state correlates with the degree of gain-of-function activity and clinical severity. Our data demonstrate that the fractional population of RTKs in the active state determines intrinsic kinase activity and underscore how a slight increase in the active population of kinases can have grave consequences for human health.

Legend

Protein

Chemical

Disease

Primary Citation of related structures